Bettamousse 0.1% cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bettamousse 0.1% cutaneous foam

mawdsley-brooks & company ltd - betamethasone valerate - cutaneous foam - 1mg/1gram

Qutenza 179mg cutaneous patches United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

qutenza 179mg cutaneous patches

grunenthal ltd - capsaicin - cutaneous patch - 179mg

Bettamousse 0.1% cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bettamousse 0.1% cutaneous foam

necessity supplies ltd - betamethasone valerate - cutaneous foam - 1mg/1gram

Bettamousse 0.1% cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bettamousse 0.1% cutaneous foam

de pharmaceuticals - betamethasone valerate - cutaneous foam - 1mg/1gram

Actikerall 5mg/g / 100mg/g cutaneous solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actikerall 5mg/g / 100mg/g cutaneous solution

almirall ltd - fluorouracil; salicylic acid - cutaneous solution - 5mg/1gram ; 100mg/1gram

Soleve Sunburn Relief cutaneous emulsion United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

soleve sunburn relief cutaneous emulsion

diomed developments ltd - cutaneous emulsion

Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

enstilar 50micrograms/g / 0.5 mg/g cutaneous foam

leo pharma - betamethasone dipropionate; calcipotriol monohydrate - cutaneous foam - 500microgram/1gram ; 50microgram/1gram

CO-DIOVAN 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; iron oxide red; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; macrogol 8000; magnesium stearate; hypromellose; colloidal anhydrous silica - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; iron oxide yellow; colloidal anhydrous silica; crospovidone; purified talc; magnesium stearate; hypromellose; macrogol 8000; iron oxide red; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.